Are we ready to restrict EGFR therapy to quadruple-negative colorectal cancer?
Eliza Hawkes, David Cunningham
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
François-Xavier Mahon, Delphine Réa, Joëlle Guilhot, François Guilhot, Françoise Huguet, Franck Nicolini, Laurence Legros, Aude Charbonnier, Agnès Guerci, Bruno Varet, Gabriel Etienne, Josy Reiffers, Philippe Rousselot, on behalf of the Intergroupe Français des Leucémies Myéloïdes Chroniques (FILMC)
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial
Eckhard Thiel, Agnieszka Korfel, Peter Martus, Lothar Kanz, Frank Griesinger, Michael Rauch, Alexander Röth, Bernd Hertenstein, Theda von Toll, Thomas Hundsberger, Hans-Günther Mergenthaler, Malte Leithäuser, Tobias Birnbaum, Lars Fischer, Kristoph Jahnke, Ulrich Herrlinger, Ludwig Plasswilm, Thomas Nägele, Torsten Pietsch, Michael Bamberg, Michael Weller
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose, Wim GV Quint, Laia Alemany, Daan T Geraets, Jo Ellen Klaustermeier, Belen Lloveras, Sara Tous, Ana Felix, Luis Eduardo Bravo, Hai-Rim Shin, Carlos S Vallejos, Patricia Alonso de Ruiz, Marcus Aurelho Lima, Nuria Guimera, Omar Clavero, Maria Alejo, Antonio Llombart-Bosch, Chou Cheng-Yang, Silvio Alejandro Tatti, Elena Kasamatsu, Ermina Iljazovic, Michael Odida, Rodrigo Prado, Muhieddine Seoud, Magdalena Grce, Alp Usubutun, Asha Jain, Gustavo Adolfo Hernandez Suarez, Luis Estuardo Lombardi, Aekunbiola Banjo, Clara Menéndez, Efrén Javier Domingo, Julio Velasco, Ashrafun Nessa, Saibua C Bunnag Chichareon, You Lin Qiao, Enrique Lerma, Suzanne M Garland, Toshiyuki Sasagawa, Annabelle Ferrera, Doudja Hammouda, Luciano Mariani, Adela Pelayo, Ivo Steiner, Esther Oliva, Chris JLM Meijer, Waleed Fahad Al-Jassar, Eugenia Cruz, Thomas C Wright, Ana Puras, Cecilia Ladines Llave, Maria Tzardi, Theodoros Agorastos, Victoria Garcia-Barriola, Christine Clavel, Jaume Ordi, Miguel Andújar, Xavier Castellsagué, Gloria I Sánchez, Andrzej Marcin Nowakowski, Jacob Bornstein, Nubia Muñoz, F Xavier Bosch, on behalf of the Retrospective International Survey and HPV Time Trends Study Group
Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial
Annemiek Broyl, Sophie L Corthals, Joost LM Jongen, Bronno van der Holt, Rowan Kuiper, Yvonne de Knegt, Mark van Duin, Laila el Jarari, Uta Bertsch, Henk M Lokhorst, Brian G Durie, Hartmut Goldschmidt, Pieter Sonneveld
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
Michel Bolla, Geertjan Van Tienhoven, Padraig Warde, Jean Bernard Dubois, René-Olivier Mirimanoff, Guy Storme, Jacques Bernier, Abraham Kuten, Cora Sternberg, Ignace Billiet, José Lopez Torecilla, Raphael Pfeffer, Carmel Lino Cutajar, Theodore Van der Kwast, Laurence Collette
REVIEW
New drugs for aggressive B-cell and T-cell lymphomas
Niels Murawski, Michael Pfreundschuh
Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues
Michel Delforge, Joan Bladé, Meletios A Dimopoulos, Thierry Facon, Martin Kropff, Heinz Ludwig, Antonio Palumbo, Philip Van Damme, Jesús F San-Miguel, Pieter Sonneveld
Glucocorticoid use in acute lymphoblastic leukaemia
Hiroto Inaba, Ching-Hon Pui
